Showing 6901 - 6910 of 7186 for "Trade mark" with applied filters
11 January 2023 by Rob Rodrigues, Danielle Altomari, Priscila Figueiredo, Ivan Domith
The healthcare sector in Brazil is one of the most important in the world in view of the size of the population (+220 million people) and the availability of a universal public healthcare system. The action of antibodies as therapeutic agents may involve processes of neutralization, opsonization and activation of immune complement system, transforming them into a progressively desirable tool in medicine. In view of this, the interaction between IP and these innovative therapies deserves special attention.
01 December 2022 by Licks Attorneys - Brazil
Licks Attorneys announced the promotion of two attorneys at law to partners
19 October 2022 by Anand and Anand
In a case involving Bridgestone, Delhi High Court interpreted the Indian law relating to international applications under the Madrid Protocol
04 October 2022 by Hoffmann Eitle
Hoffmann Eitle today announced that it has selected Symphony, from MaxVal Group, as its new Intellectual Property Management System to serve as an integral part of a firm-wide transformation initiative
14 February 2022 by LexOrbis
Manisha Singh and Niti Vyas of LexOrbis consider the findings of a Delhi High Court case that looks at how registered trademarks are used as keywords
01 September 2021 by Manisha Singh and Pankaj Musyuni
Manisha Singh and Pankaj Musyuni of LexOrbis discuss how patent rights are impeding access to medicines and what can be done to minimise the damage caused by COVID-19
09 August 2021 by Jason Cheah and Chew Qi-Guang
Jason Cheah and Chew Qi-Guang of Henry Goh & Co discuss the latest updates in Malaysian IP law and the proposed legislative changes
02 August 2021 by Bird & Bird
Bird & Bird’s IP lawyers summarise some of the notable patent decisions in the Netherlands last year
16 June 2021 by Lili Wu, Ying Li, Yulian Hu and Linlin Zhang
Lili Wu, Ying Li, Yulian Hu and Linlin Zhang of Han Kun Law Offices explain how China’s drug-patent linkage system promotes and encourages innovation and development of the pharmaceutical industry
10 June 2021 by Crystal J Chen and Nick J C Lan
Crystal J Chen and Nick J C Lan of Tsai Lee & Chen examine the case law on post-sale confusion in other jurisdictions and considers how Taiwan’s IP Court has embraced the concept